Walker Marlan D
Chief Executive Officer at TXMD
- Sold, on record
- $76k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Dec 7, 2023
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- TXMDTherapeuticsMD, Inc.Chief Executive Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale TXMDUnusualMay 11 2021
Sold 21,592 shares at $1.04 ($22k)
Walker Marlan D, General Counsel
Sold 42.8% of holdings ($53k position)28,908 shares leftFirst sale on recordFiling
- 2 Form 4 sale TXMDPlan not statedDec 6 +574 days
Sold 1,048 shares at $4.95 ($5k)
Walker Marlan D, General Counsel
Sold 13.6% of holdings ($38k position)6,685 shares leftFiling
- 3 Form 4 sale TXMDNo planApr 12 +127 days
Sold 1,170 shares at $3.65 ($4k)
Walker Marlan D, Chief Executive Officer
No 10b5-1 planSold 8.7% of holdings ($49k position)12,307 shares leftFiling
- 4 Form 144 notice TXMDNoticeDec 6 +238 days
Filed to sell 28,134 shares ($70k)
Walker Marlan D, Officer
No 10b5-1 planFiling
- 5 Form 4 sale TXMDNo planDec 7 +1 day
Sold 19,050 shares at $2.29 ($44k)
Walker Marlan D, Chief Executive Officer
No 10b5-1 planSold 23.3% of holdings ($187k position)62,565 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (5)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2023 | TXMD | Chief Executive Officer | Form 4 sale | 19,050 | $44k | 23.3% | No plan | SEC |
| Dec 6, 2023 | TXMD | Officer | Form 144 notice | 28,134 | $70k | Notice | SEC | |
| Apr 12, 2023 | TXMD | Chief Executive Officer | Form 4 sale | 1,170 | $4k | 8.7% | No plan | SEC |
| Dec 6, 2022 | TXMD | General Counsel | Form 4 sale | 1,048 | $5k | 13.6% | Plan not stated | SEC |
| May 11, 2021 | TXMD | General Counsel | Form 4 sale | 21,592 | $22k | 42.8% | Unusual | SEC |